enGene Holdings Inc. Files 10-K/A Amendment
Ticker: ENGNW · Form: 10-K/A · Filed: Feb 20, 2025 · CIK: 1980845
Sentiment: neutral
Topics: amendment, annual-report, sec-filing
TL;DR
enGene Holdings filed an amendment to its 2024 annual report, check for updates.
AI Summary
enGene Holdings Inc. filed an amendment (10-K/A) on February 20, 2025, for its fiscal year ending October 31, 2024. The company, located at 4868 Rue Levy, Suite 220, Saint-Laurent, QC, Canada, operates in the biological products sector. This filing provides updated information for their annual report.
Why It Matters
This amendment provides updated financial and operational information for enGene Holdings Inc., crucial for investors and stakeholders to assess the company's performance and outlook.
Risk Assessment
Risk Level: low — This filing is an amendment to an annual report, typically containing updated disclosures rather than new material events.
Key Numbers
- 20241031 — Fiscal Year End (The period covered by the annual report.)
- 20250220 — Filing Date (The date the amendment was submitted to the SEC.)
Key Players & Entities
- enGene Holdings Inc. (company) — Registrant
- 001-41854 (company) — Commission File Number
- 4868 Rue Levy, Suite 220 Saint-Laurent , QC , Canada H4R 2P1 (company) — Principal executive offices address
- October 31 , 2024 (date) — Fiscal year end
- 20250220 (date) — Filing date
FAQ
What is the purpose of this 10-K/A filing?
This is an amendment (Amendment No. 1) to the Annual Report on Form 10-K for the fiscal year ended October 31, 2024, indicating updates or corrections to the original filing.
What is the company's full legal name and jurisdiction of incorporation?
The company's full name is enGene Holdings Inc., and it is incorporated in British Columbia, Canada.
What is the principal executive office address of enGene Holdings Inc.?
The principal executive offices are located at 4868 Rue Levy, Suite 220, Saint-Laurent, QC, Canada H4R 2P1.
What is the SIC code for enGene Holdings Inc.?
The Standard Industrial Classification (SIC) code is 2836, which corresponds to Biological Products (No Diagnostic Substances).
When was the original 10-K filed or when is this amendment being filed?
The amendment (10-K/A) was filed on February 20, 2025, for the fiscal year ended October 31, 2024.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on February 20, 2025 regarding enGene Holdings Inc. (ENGNW).